HAYWARD, Calif., February 07, 2024–Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing …
HAYWARD, Calif., February 07, 2024–Arcus Biosciences (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing …
In